Published 60-day Federal Register Notice

66975

Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents

Number of
respondents

Form name

Total ..................................................

Number of
responses
per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

Action Plan Annual Objectives & Activities & Updates.

53

2

11.5

1,219

..................................................................

....................

....................

......................

4,134

Dated: December 8, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–29971 Filed 12–16–09; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–10–0009]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to [email protected].

Jakob Disease (CJD), Cyclospora,
Dengue, Hantavirus, Kawasaki
Syndrome, Legionellosis, Lyme disease,
Malaria, Plague, Q Fever, Reye
Syndrome, Tickborne Rickettsial
Disease, Trichinosis, Tularemia,
Typhoid Fever, and Viral Hepatitis. This
revision entails the discontinuation of
the two Active Bacterial Surveillance
(ABCs) forms which now collect data
under a separate OMB control number,
0920–0802. Case report forms from state
and territorial health departments
enable CDC to collect demographic,
clinical, and laboratory characteristics
of cases of these diseases.
The purpose of the proposed study is
to direct epidemiologic investigations,
identify and monitor trends in
reemerging infectious diseases or
emerging modes of transmission, to
search for possible causes or sources of
the diseases, and develop guidelines for
prevention and treatment. The data
collected will also be used to
recommend target areas most in need of
vaccinations for selected diseases and to
determine development of drug
resistance. Because of the distinct
nature of each of the diseases, the
number of cases reported annually is
different for each. There is no cost to
respondents other than their time.

Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Disease Surveillance
Program (OMB No. 0920–0009 Exp.
3/31/2010)—Revision—National Center
for Zoonotic, Vector-borne, and Enteric
Diseases (NCZVED), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Formal surveillance of 17 separate
reportable diseases has been ongoing to
meet the public demand and scientific
interest in accurate, consistent,
epidemiologic data. These ongoing
disease reports include: Creutzfeldt-

ESTIMATED ANNUALIZED BURDEN HOURS

wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1

Form

CJD ...................................................
Cyclosporiasis ...................................
Dengue ..............................................
Hantavirus .........................................
Kawasaki Syndrome .........................
Legionellosis .....................................
Lyme Disease ...................................
Malaria ..............................................
Plague ...............................................
Q Fever .............................................
Reye Syndrome ................................
Tick-borne Rickettsia ........................
Trichinosis .........................................
Tularemia ..........................................
Thphoid fever ....................................
Viral hepatitis ....................................

VerDate Nov<24>2008

13:19 Dec 16, 2009

Number of
respondents

Type of respondent

Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist

Jkt 220001

PO 00000

..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................

Frm 00025

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

20
55
55
46
55
23
52
55
11
55
50
55
25
55
55
55

E:\FR\FM\17DEN1.SGM

2
10
182
3
8
12
385
20
1
1
1
18
1
2
6
200

17DEN1

Average
burden per
response
(in hours)
20/60
15/60
15/60
20/60
15/60
20/60
10/60
15/60
20/60
10/60
20/60
10/60
20/60
20/60
20/60
25/60

Total burden
hours
13
138
2503
46
110
92
3337
275
4
9
17
165
8
37
110
4583

66976

Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent

Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

...........................................................

........................

........................

........................

Form

Total ...........................................

Dated: December 10, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–30015 Filed 12–16–09; 8:45 am]

use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.

BILLING CODE 4163–18–P

Proposed Project

Centers for Disease Control and
Prevention
[60Day-10–0761]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the

11,447

not found evidence for the effectiveness
of screening to improve outcomes for
women exposed to IPV.
Based on the recommendations of an
expert panel convened, CDC is
proposing to conduct a randomized
controlled trial to provide this evidence.
The trial will recruit 2675 women in a
network of women’s health clinics.
Women attending these clinics tend to
be African American and of lower
socioeconomic status. For this study,
women will be randomly allocated to
one of three arms: (1) Screened for IPV,
and if disclosing IPV, provided
information on available IPV services;
(2) not screened and all receiving
information on available IPV services; or
(3) a control group that will not be
screened nor receive information on
available IPV services. All three arms
will be assessed with a self-report
measure for disability, quality of life,
and utilization of health services at
baseline utilizing an audio-computerassisted structured interview (A–CASI)
and at a 12-month follow-up utilizing a
computerized-assisted telephone
interview (CATI). The results from this
Randomized Controlled Trial, will guide
CDC as well as other governmental
agencies, professional and health care
organizations, and women’s advocate
groups in formulating its
recommendations and policies
regarding routine screening. A pretest
with 196 women in a women’s health
clinic was conducted to test the
enrollment, randomization, interview,
and follow-up procedures; and provide
estimates for outcome measures. Based
on the results of the pretest, CDC has
revised the measures, procedures, and
sample size requirements for the
Randomized Controlled Trial. There are
no costs to respondents other than their
time to participate in the survey.

Randomized Controlled Trial of
Routine Screening for Intimate Partner
Violence (OMB No. 0920–0761 Exp. 1/
31/2011)—Revision—National Center
for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Total burden
hours

Background and Brief Description
Intimate partner violence (IPV) is a
prevalent problem with serious health
consequences that include death,
physical injury, increased rates of
physical illness, posttraumatic stress,
increased psychological distress,
depression, substance abuse, and
suicide. Some studies suggest that abuse
perpetrated by intimate partners tends
to be repetitive and escalates in severity
over time. This research has been the
basis for promoting early diagnosis and
intervention.
Health care providers appear to be
well situated to identify IPV. Women
come into contact with health care
services routinely for a number of
reasons such as prenatal care, family
planning, cancer screening, and well
baby care. Women experiencing IPV
make more visits to emergency
departments, primary care facilities, and
mental health agencies than non-abused
women. Considering the magnitude and
severity of IPV, and the potential role
health care providers could play in
reducing its serious consequences,
numerous professional and health care
organizations have recommended
routine screening of women for IPV in
primary care settings. However, various
systematic reviews of the literature have

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Number of
responses per
respondent

Average
burden
response
(in hours)

Annual burden
(in hours)

Type of respondents

Form name

Women Seeking Health Care Services.

Eligibility Script for Pretest ...............

70

1

1/60

2

Baseline Questionnaire Pretest .......
Follow-up Questionnaire Pretest ......

65
59

1
1

15/60
12/60

17
12

VerDate Nov<24>2008

13:19 Dec 16, 2009

Jkt 220001

PO 00000

Frm 00026

Fmt 4703

Sfmt 4703

E:\FR\FM\17DEN1.SGM

17DEN1